|
|
|
15.04.25 - 07:33
|
Galapagos Announces Departure of Thad Huston, CFO and COO, as of August 1, 2025 (GlobeNewswire EN)
|
|
Mechelen, Belgium; April 15, 2025, 07:30 CET; regulated information – inside information – Galapagos NV (Euronext & NASDAQ: GLPG), a global biotechnology company dedicated to transforming patient outcomes through life-changing science and innovation, today announced the departure of its CFO and COO, Thad Huston, effective as of August 1, 2025. Mr. Huston has decided to leave the company and return to the U.S. for personal and professional reasons. Mr. Huston joined Galapagos NV in 2023 from Kite Pharma, Inc., to support Galapagos' transformation into a cell therapy company. The company expects to announce Mr. Huston's successor in the coming months.Paul Stoffels1, MD, CEO and Chair of the Board of Directors of Galapagos, said “Over the past two years, Thad has worked on the transformation of Galapagos into a focused cell therapy business leveraging our unique decentralized cell therapy platform to deliver fresh, stem-like early memory CAR-T therapy with a vein-to-vein time of seven days. Thad wil...
|
|
|
|
|
|
|
|
|
|
|
|
07.04.25 - 07:15
|
Azelis Nominates Lily Wang to Board of Directors (Business Wire)
|
|
ANTWERP, Belgium--(BUSINESS WIRE)--Regulatory News:
Azelis (Brussels:AZE), the reference innovation service provider in the speciality chemicals and food ingredients industry, announces the nomination of Lily Wang as a non-executive and independent director. With over 20 years of significant international business experience in the chemicals industry, Ms. Wang's extensive expertise will further contribute to strengthening Azelis's strategy.
As from 8 May, Ms. Wang would be succeeding Ipek Özsüer, who has provided significant contributions to our digitalisation efforts since joining the Board of Directors in 2021. Ms. Wang's appointment is subject to approval by the shareholders of Azelis Group NV at the Annual General Meeting.
Beginning her professional career in China with Bayer Group in 2002, Ms. Wang has held numerous executive roles across Europe, Asia and America at both Bayer and, subsequently, Covestro, including Senior Vice President, Global Electronic, Electrical and Appliance and Global Dis...
|
|
|
|
|
|
|
|